![]()
|
|
||||||||
J. Biol. Chem., Vol. 269, Issue 16, 11934-11937, Apr, 1994
D Prager, HL Li, H Yamasaki and S Melmed
Cytoplasmic submembrane domains of the insulin-like growth factor I (IGF-1)
receptor ranging from glycine 940 to proline 959 were investigated for
their role in endocytosis of the IGF-1 ligand in rat pituitary GC cells
stably expressing mutant human IGF-1 receptors. Replacement of each of
three tyrosine residues within the juxtamembrane domain reduced the
internalization rate (Ke) by 33% (943Y-->A), 47% (950Y-->A), and 41%
(957Y-->A), respectively. Other substitutions within the submembrane
region variably retarded receptor-mediated IGF-1 ligand endocytosis. Thus,
each amino acid appears to independently contribute to the overall
ligand-stimulated IGF-1 receptor internalization rate. The effect of
receptor occupancy on IGF-1 receptor endocytosis was also tested. The rate
of 125I-labeled IGF-1 internalization by transfectants overexpressing the
wild type IGF-1 receptor was rapid but decreased markedly in the presence
of increasing unlabeled IGF-1 (ED50 = 44,000 receptors/cell). Substitution
by alanine for any of the three submembrane tyrosines increased the ED50 to
> 56,000 receptors/cell, decreased the slope (Kic), and had a variable
effect on Vmax in the presence of increasing unlabeled IGF-1. In contrast,
125I-labeled IGF-1 endocytosis by the mutant kinase-deficient 952STOP cells
was slow and not further retarded by unlabeled IGF-1. These results suggest
that ligand-mediated internalization of the human IGF-I is consistent with
saturable interactions between the IGF-I receptor juxtamembrane region
(glycine 940-tyrosine 957) and components of the endocytic apparatus.
Human insulin-like growth factor I receptor internalization. Role of the juxtamembrane domain
Department of Medicine, Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine 90048.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Chi-Hang Li and R. Li RAV12 Accelerates the Desensitization of Akt/PKB Pathway of Insulin-like Growth Factor I Receptor Signaling in COLO205 Cancer Res., September 15, 2007; 67(18): 8856 - 8864. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Haft, M. de La Luz Sierra, I. Hamer, J.-L. Carpentier, and S. I. Taylor Analysis of the Juxtamembrane Dileucine Motif in the Insulin Receptor Endocrinology, April 1, 1998; 139(4): 1618 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Peterson, G. Kulik, T. Jelinek, C. W.M. Reuter, J. A. Shannon, and M. J. Weber Src Phosphorylates the Insulin-like Growth Factor Type I Receptor on the Autophosphorylation Sites. REQUIREMENT FOR TRANSFORMATION BY src J. Biol. Chem., December 6, 1996; 271(49): 31562 - 31571. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |